Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Infectious diseases
Published: April 05, 2026
Autoimmune disease is associated with heightened long COVID risk but prior immunization is protective.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 05, 2025
Variability in vaccination practices in children with rheumatic diseases: results of a childhood arthritis and rheumatology research alliance (CARRA)-wide survey.
Journal: Pediatric rheumatology online journal
Published: June 19, 2025
Age-Related Changes in the Clinical Picture of Long COVID.
Journal: Journal of the American Geriatrics Society
Published: June 05, 2025
Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study.
Journal: Lupus science & medicine
Published: June 02, 2025
2024 Update of the RECOVER-Adult Long COVID Research Index.
Journal: JAMA
Published: December 18, 2024
Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.
Journal: PloS one
Published: October 30, 2024
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.
Journal: Annals of internal medicine
Published: August 12, 2024
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study.
Journal: Journal of general internal medicine
Published: August 01, 2024
Opportunities in childhood Sjögren's disease: results from collaborative roundtable discussions.
Journal: Rheumatology (Oxford, England)
Published: April 23, 2024
Trained mesenchymal stromal cell-based therapy HXB-319 for treating diffuse alveolar hemorrhage in a pristane-induced murine model.
Journal: Stem cells (Dayton, Ohio)
Published: January 18, 2024
Last Updated: 09/26/2026